By Josh White
Date: Tuesday 20 Aug 2024
(Sharecast News) - N4 Pharma, a specialist pharmaceutical company focused on the development of Nuvec, a novel delivery system for cancer treatments, gene therapy, and vaccines, updated the market on its collaboration with SRI International on Tuesday.
By Benjamin Chiou
Date: Friday 07 Jun 2024
(Sharecast News) - Shares in small-cap pharma group N4 Pharma sank on Friday after the company announced a share placing and subscription to raise £630,000.
By Josh White
Date: Thursday 15 Feb 2024
(Sharecast News) - N4 Pharma announced a significant advancement in the development of Nuvec, an innovative delivery system tailored for cancer treatments, gene therapy, and vaccines, on Thursday.
Currency | UK Pounds |
Share Price | 0.65p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 3.07 |
52 Week Low | 0.50 |
Volume | 168,735 |
Shares Issued | 394.78m |
Market Cap | £2.57m |
Value |
---|
Value |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
13:32 | 214 @ 0.70p |
13:17 | 9,273 @ 0.67p |
12:14 | 255 @ 0.70p |
11:23 | 50,000 @ 0.63p |
11:22 | 3,726 @ 0.63p |
You are here: research